Silver-Catalyzed Enantioselective Intermolecular γ-Amination of β,γ-Unsaturated Amide

  • Jun Ding ,
  • Xiaokun Shi ,
  • Yu Hao ,
  • Heyuan Bai ,
  • Shuyu Zhang
Expand
  • School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240

Received date: 2022-11-16

  Revised date: 2023-03-05

  Online published: 2023-04-10

Supported by

The National Natural Science Foundation of China(22071147)

Abstract

Unnatural γ-amino acid structures are widely present in natural products and drug molecules. Therefore, the synthesis of unnatural amino acids through direct asymmetric amination reaction has important research and application values. An efficient γ-amination reaction using azodicarboxylate as nitrogen source is reported. The asymmetric reaction of azodicarboxylate with β,γ-unsaturated amides was realized by using monovalent silver as Lewis acid catalyst and biphenyl axial chiral bisphosphine compound as ligand. The reaction has good substrate applicability, and a series of chiral γ-amino acid derivatives were obtained in moderate yields with an enantioselectivity of 90% ee.

Cite this article

Jun Ding , Xiaokun Shi , Yu Hao , Heyuan Bai , Shuyu Zhang . Silver-Catalyzed Enantioselective Intermolecular γ-Amination of β,γ-Unsaturated Amide[J]. Chinese Journal of Organic Chemistry, 2023 , 43(8) : 2946 -2952 . DOI: 10.6023/cjoc202211019

References

[1]
(a) Müller, P.; Fruit, C. Chem. Rev. 2003, 103, 2905.
[1]
(b) Hili, R.; Yudin, A. K. Nat. Chem. Biol. 2006, 2, 284.
[1]
(c) Br?se, S. ChemBioChem 2008, 9, 1509.
[1]
(d) Valeur, E.; Bradley, M. Chem. Soc. Rev. 2009, 38, 606.
[1]
(e) Cho, S. H.; Kim, J. Y.; Kwak, J.; Chang, S. Chem. Soc. Rev. 2011, 40, 5068.
[1]
(f) Chen, Y.; Zhu, J.; Zhao, S. Chin. J. Org. Chem. 2019, 39, 1923. (in Chinese)
[1]
( 陈樱, 祝家楠, 赵圣印, 有机化学, 2019, 39, 1923.)
[2]
(a) Chebib, M.; Johnston, G. A. R. Clin. Exp. Pharmacol. Physiol. 1999, 26, 937.
[2]
(b) Ordó?ez, M.; Cativiela, C. Tetrahedron: Asymmetry 2007, 18, 3.
[2]
(c) Sigel, E.; Steinmann, M. E. J. Biol. Chem. 2012, 287, 40224.
[3]
Lapin, I. CNS Drug Rev. 2001, 7, 471.
[4]
(a) Chizh, B. A.; G?hring, M.; Tr?ster, A.; Quartey, G. K.; Schmelz, M.; Koppert, W. Br. J. Anaesth. 2007, 98, 246.
[4]
(b) Ha, K.-Y.; Carragee, E.; Cheng, I.; Kwon, S.-E.; Kim, Y.-H. J. Korean Med. Sci. 2011, 26, 404.
[5]
(a) Bertelsen, S.; Marigo, M.; Brandes, S.; Dinér, P.; J?rgensen, K. A. J. Am. Chem. Soc. 2006, 128, 12973.
[5]
(b) Wang, J.; Chen, J.; Kee, C. W.; Tan, C.-H. Angew. Chem., Int. Ed. 2012, 51, 2382.
[5]
(c) Takeda, T.; Terada, M. J. Am. Chem. Soc. 2013, 135, 15306.
[5]
(d) Yang, X.; Toste, F. D. J. Am. Chem. Soc. 2015, 137, 3205.
[5]
(e) Chen, X.; Liu, X.; Mohr, J. T. Org. Lett. 2016, 18, 716.
[5]
(f) Shang, M.; Wang, X.; Koo, S. M.; Youn, J.; Chan, J. Z.; Yao, W.; Hastings, B. T.; Wasa, M. J. Am. Chem. Soc. 2017, 139, 95.
[6]
(a) Bai, H.-Y.; Ma, Z.-G.; Yi, M.; Lin, J.-B.; Zhang, S.-Y. ACS Catal. 2017, 7, 2042.
[6]
(b) Fu, X.; Bai, H.-Y.; Zhu, G.-D.; Huang, Y.; Zhang, S.-Y. Org. Lett. 2018, 20, 3469.
[6]
(c) Fu, X.; Hao, Y.; Bai, H.-Y.; Duan, A.; Zhang, S.-Y. Org. Lett. 2021, 23, 25.
[6]
(d) Qiu, X.-Y.; Li, Z.-H.; Zhou, J.; Lian, P.-F.; Dong, L.-K.; Ding, T.-M.; Bai, H.-Y.; Zhang, S.-Y. ACS Catal. 2022, 12, 7511.
[7]
Zhang, H.-J.; Shi, C.-Y.; Zhong, F.; Yin, L. J. Am. Chem. Soc. 2017, 139, 2196.
Outlines

/